Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Science News
  • Resources

Cancer

Breast self-examination Breast Cancer Awareness Month - October 2026 Breast Cancer Targeted Therapies

Breast Cancer Targeted Therapies and Immunotherapies

Antibody-drug conjugates, Biologics, Cancer, Monoclonal antibody
PD-1-Antibody-Development-Programs-for-Cancer-Immunotherapy

PD-1 Antibody Development Programs for Cancer Immunotherapy

Bispecific antibody, Cancer, Drug substance, Manufacturing, Monoclonal antibody
Popular receptor targets for oncologic bispecific antibodies

Oncologic Bispecific Antibodies in Immunotherapy

Biologics, Bispecific antibody, Cancer, Drug development
antibody drug-conjugates development

Breaking Barriers in Antibody-Drug Conjugates Development

Antibody-drug conjugates, Cancer
latest trends in the prevention and treatment of cervical cancer

Latest trends in the prevention and treatment of cervical cancer

Cancer, Vaccines

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo